Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2005
10/20/2005US20050233453 6-O-sulfated N-acetylheparosan and hematopoietic stem cell growth auxiliary agent
10/20/2005CA2806465A1 Ion binding polymers and uses thereof
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2561222A1 Combination dosing regimen for erythropoietin
10/19/2005EP1586646A2 Lawsonia intracellularis vaccine
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586586A2 Peptide and/or proteins and their use for the manufacture of a therapeutic and/or preventive medicament
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586565A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
10/19/2005EP1586328A1 Agent for improving life expectancy in therapy of malignant tumor
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2005EP1585730A1 Carboxamide derivatives and their use as factor xa inhibitors
10/19/2005EP1414837B1 Adenosine a3 receptor agonists
10/19/2005EP1144373B1 Serine protease inhibitors
10/19/2005EP1070714A9 Amidine compounds
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684702A Method of treating tumors
10/19/2005CN1684684A Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683373A Thiophenopyridine substituted acetyl hyarazine derivative
10/19/2005CN1683018A Gene engineering vaccine for weaning pigling diarrhea and pig hydrops disease
10/19/2005CN1682978A Compound ass-hide gelatin soft capsule and its preparing method
10/19/2005CN1682966A Yunnan Manyleaf paris Rhizome extract ora disintegration tablet and its preparing process
10/19/2005CN1682931A Xuening dripping pill having hemostatic function and its preparing method
10/19/2005CN1682928A Novel process for preparing Mailuoing freeze-dried powder injection
10/19/2005CN1682885A Hemostatic preparation for gynecology department
10/19/2005CN1682802A Heart and brain health dripping pill for refreshing and strengthening brain and its preparing method
10/19/2005CN1682764A Bone strengthening oral liquor and its preparing method
10/19/2005CN1682761A Hemostatic agent and its preparing method
10/19/2005CN1682707A Pharmaceutical composition comprising fenofibrate and process for its preparation
10/19/2005CN1223578C Medical compound with antalgic, anti-inflammation and thrombocyte decoagulation function
10/19/2005CN1223366C Hemostat and its usage
10/19/2005CN1223358C Chinese medicinal herbs preparation for treating nephritic syndrome and its preparing method
10/19/2005CN1223351C Use of low-molecular-weight heparins for preventing and treating cerebral edemas
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223345C Pharmaceutical composition of anti-platelet aggregation
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956106 Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956022 Increasing blood platelet formation by administering a parathyroid hormone or a derivative
10/18/2005US6955682 Wound closure system and methods
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2006929C Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
10/13/2005WO2005095427A1 Composition for prevention or treatment of thrombosis
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095373A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095372A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005094918A1 Solid pharmaceutical preparation for dialysis
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094823A1 Flt-3 INHIBITOR
10/13/2005WO2005069717A3 The use os anti-rh antibodies for treating acute thrombocytopenia associated with dengue hemorrhagic fever, hepatitis c and other microbial infections
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228011 use of carboxy-functional benzofurans or benzothiophenes to treat tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, and sickle cell anemia; greater bioavailability or fewer side-effects
10/13/2005US20050228001 Methods and compositions for treating platelet-related disorders
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227280 Proteases
10/13/2005US20050226916 Hemostatic polymer useful for RAPID blood coagulation and hemostasis
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2561732A1 Antibody drug
10/13/2005CA2557061A1 Factor ixa for the treatment of bleeding disorders
10/12/2005EP1584925A1 Novel screening method
10/12/2005EP1583587A2 Organic compounds with biological action as thrombin inhibitors and use therof
10/12/2005EP1583550A2 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia
10/12/2005EP1583526A1 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
10/12/2005EP1478362B1 A combination treatment for acute myocardial infarction
10/12/2005EP1274721B1 Haemostatically active preparation containing vwf and method for the production thereof
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1169322B1 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
10/12/2005EP0999834B1 Antithrombotic agents
10/12/2005EP0793723B1 New staphylokinase derivatives
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681521A Method for purifying a biological composition
10/12/2005CN1681509A Slow release preparation containing larmotriazine
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681499A Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/12/2005CN1680449A Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol
10/12/2005CN1680414A Preparation of Chinese medicine clinopodium polycephalum saponin
10/12/2005CN1680377A 4-oxo-4, 6, 7, 8-tetrahydro-pyrrolo[1, 2-a]pyrazine-6-carboxamide compounds
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1679925A Sustained releasing microspheric preparation of glucokinase mutant and its making method
10/12/2005CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist
10/12/2005CN1679902A Chinese medicine preparation for treating hematophilia
10/12/2005CN1679883A Compound light-yellow sophora root freeze-drying injection and preparation thereof
10/12/2005CN1679827A Method for making substrate for paste from Chinese prickly ash and oral medicinal materials
10/12/2005CN1679825A Powdery wound paste with instant soluble seal and production thereof
10/12/2005CN1679786A Chinese medicine preparation for treating bleeding, preparation and quality control thereof
10/12/2005CN1679778A Chinese medicinal preparation for dilating coronary artery and preventing from platelet aggregation
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 671